How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
- 1 November 2010
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 11 (11) , 1011-1012
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialThe Lancet Oncology, 2010
- Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapyJournal of Neuro-Oncology, 2008
- Pathway analysis of primary central nervous system lymphomaBlood, 2008
- A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 casesBlood, 2005
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992